Advanced Search
XIA Ying, LONG Jiayi, DAI Haoran, SHEN Mengyuan, GUO Hongli, HU Yahui, CHEN Feng. Determination of digoxin in human plasma by LC-MS/MS and its application in pediatric patients[J]. Journal of China Pharmaceutical University, 2021, 52(6): 719-724. DOI: 10.11665/j.issn.1000-5048.20210610
Citation: XIA Ying, LONG Jiayi, DAI Haoran, SHEN Mengyuan, GUO Hongli, HU Yahui, CHEN Feng. Determination of digoxin in human plasma by LC-MS/MS and its application in pediatric patients[J]. Journal of China Pharmaceutical University, 2021, 52(6): 719-724. DOI: 10.11665/j.issn.1000-5048.20210610
shu

Determination of digoxin in human plasma by LC-MS/MS and its application in pediatric patients

  • 1.

    Pharmaceutical Sciences Research Center, Department of Pharmacy, Children's Hospital of Nanjing Medical University, Nanjing 210008

  • 2.

    School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 210009

  • 3.

    Kangda College of Nanjing Medical University, Lianyungang 222000 , China

Funds: This study was supported by Specially-Appointed Medical Expert Project of Jiangsu Provincial Commission of Health (2019)
More Information
  • Received Date: August 23, 2021
  • Revised Date: November 03, 2021
    Graphical Abstract
    • Abstract
  • The aim of the study was to develop a simple, rapid and accurate LC-MS/MS method for the determination of digoxin.Digoxin-d3 was taken as the internal standard (IS), and sample preparation was achieved by liquid-liquid extraction.Chromatographic separation was performed on a Kinetex C18 column (2.1 mm × 50 mm, 2.6 μm; Phenomenex) using an isocratic elution with merely 2 min for each sample.The mobile phase consisted of water and acetonitrile solutions, both containing 1 mmol/L ammonium acetate and 1 mmol/L formic acid (55∶45).The detection was conducted on a TripleQuadTM 4500MD mass spectrometer coupled with electrospray ionization interface under positive-ion multiple reaction monitoring mode.The transitions were m/z 798.5 → 651.3 and m/z 801.6 → 654.4 for digoxin and digoxin-d3, respectively.Results showed that the method was linear over the range of 0.100-20.0 ng/mL.The selectivity, accuracy and precision, recovery and stability of the method were all within the acceptable limits with no matrix effect.This method was successfully applied to a girl treated with digoxin with substantial improvement of therapeutic effect and elimination of toxic reaction, so it can provide valuable fuidance and reference for individualized medication in clinical practice.
    • FullText(HTML)
    • References (14)
  • [1]
    . Crit Pathw Cardiol，2011，10（2）：93-98.
    [2]
    Abdel Jalil MH，Abdullah N，Alsous MM，et al. A systematic review of population pharmacokinetic analyses of digoxin in the paediatric population［J］. Br J Clin Pharmacol，2020，86（7）：1267-1280.
    [3]
    Grzesk G，Stolarek W，Kasprzak M，et al. Therapeutic drug monitoring of digoxin-20 years of experience［J］. Pharmacol Rep，2018，70（1）：184-189.
    [4]
    Li S，Liu G，Jia J，et al. Therapeutic monitoring of serum digoxin for patients with heart failure using a rapid LC-MS/MS method［J］. Clin Biochem，2010，43（3）：307-313.
    [5]
    Li WJ，Xu J，Xu J，et al. Data analysis of monitoring for 4 therapeutic drugs in children''s hospital ［J］. Chin New Drug J（中国新药杂志），2014，（13）：1587-1592.
    [6]
    Xia Y，Guo HL，Hu YH，et al. Therapeutic drug monitoring for monoclonal antibody：progress in the appli-cation of LC-MS/MS technique ［J］. J China Pharm Univ（中国药科大学学报），2021，52（1）：122-128.
    [7]
    Shi S，Li Z，Chen H，et al. Development and validation of an LC-MS method with electrospray ionization for quantitation of digoxin in human plasma and urine：application to a pharmacokinetic study［J］. J Chromatogr B Analyt Technol Biomed Life Sci，2008，875（2）：405-410.
    [8]
    Kirby BJ，Kalhorn T，Hebert M，et al. Sensitive and specific LC-MS assay for quantification of digoxin in human plasma and urine［J］. Biomed Chromatogr，2008，22（7）：712-718.
    [9]
    Bylda C，Thiele R，Kobold U，et al. Simultaneous quantification of digoxin，digitoxin，and their metabolites in serum using high performance liquid chromatography-tandem mass spectrometry［J］. Drug Test Anal，2015，7（10）：937-946.
    [10]
    Li X，Wang Y，Zhou Q，et al. A sensitive method for digoxin determination using formate-adduct ion based on the effect of ionization enhancement in liquid chromatograph-mass spectrometer［J］. J Chromatogr B Analyt Technol Biomed Life Sci，2015，978-979：138-144. doi：10.1016/j.jchromb.2014. 11.023.
    [11]
    Hirabayashi H，Sugimoto H，Matsumoto S，et al. Development of a quantification method for digoxin，a typical P-glycoprotein probe in clinical and non-clinical studies，using high performance liquid chromatography-tandem mass spectrometry：the usefulness of negative ionization mode to avoid competitive adduct-ion formation［J］. J Chromatogr B Analyt Technol Biomed Life Sci，2011，879（32）：3837-3844.
    [12]
    Mitamura K，Horikawa A，Yamane Y，et al. Determination of digoxin in human serum using stable isotope dilution liquid chromatography/electrospray ionization-tandem mass spectrometry［J］. Biol Pharm Bull，2007，30（9）：1653-1656.
    [13]
    Hashimoto Y，Shibakawa K，Nakade S，et al. Validation and application of a 96-well format solid-phase extraction and liquid chromatography-tandem mass spectrometry method for the quantitation of digoxin in human plasma［J］. J Chromatogr B Analyt Technol Biomed Life Sci，2008，869（1/2）：126-132.
    [14]
    Xue X，Huang M，Xiao H，et al. Rapid and simultaneous measurement of midazolam，1''-hydroxymidazolam and digoxin by liquid chromatography/tandem mass spectrometry：application to an in vivo study to simultaneously measure P-glycoprotein and cytochrome P450 3A activity［J］. J Pharm Biomed Anal，2011，55（1）：187-193.
    • Related Articles

  • Related Articles

    [1]WANG Ziyuan, TAO Hui, XIAO Yingxue, YIN Zhiqi. Network pharmacology-based study of the mechanism of Ginkgo biloba extract (GBE) in the treatment of atherosclerosis by activating PPARγ[J]. Journal of China Pharmaceutical University, 2025, 56(2): 225-235. DOI: 10.11665/j.issn.1000-5048.2024032301
    [2]DONG Xiaoqiang, WEN Chang, XU Jindan, SHI Lexue, HU Yulong, LI Jieming, DONG Chunhong, DING Kan. Research progress on active mechanism and structure feature of polysaccharides from Zizyphus jujube in Rhamnaceae plants[J]. Journal of China Pharmaceutical University, 2024, 55(4): 443-453. DOI: 10.11665/j.issn.1000-5048.2024051301
    [3]LU Zhipeng, XU Qinglong, CHEN Panpan, QIN Yajuan, TANG Lijun, LI Tingyou. Research progress of radioprobes targeting fibroblast activating protein[J]. Journal of China Pharmaceutical University, 2022, 53(6): 651-662. DOI: 10.11665/j.issn.1000-5048.20220603
    [4]MA Rui, TIAN Jinhua, JIANG Jun, JIN Xin. Inhibitory activities of ginsenosides on the activation of NLRP3 inflammasome[J]. Journal of China Pharmaceutical University, 2016, 47(5): 614-618. DOI: 10.11665/j.issn.1000-5048.20160519
    [5]ZHU Kuiniu, WU Zhengfeng, JIANG Cuihua, CAO Lanjie, ZHANG Jian, YIN Zhiqi. Advances on hypoglycemic activity and mechanism of triterpenoids[J]. Journal of China Pharmaceutical University, 2015, 46(6): 764-770. DOI: 10.11665/j.issn.1000-5048.20150622
    [6]SHEN Kai, KOU Junping, YU Boyang. Research advances in the mechanisms of active components in Chinese materia medica against oxidative stress-induced neuronal apoptosis[J]. Journal of China Pharmaceutical University, 2015, 46(5): 532-540. DOI: 10.11665/j.issn.1000-5048.20150503
    [7]WU Keqin. Antitumor activity and mechanism of saikosaponin D combined with oxaliplatin on A549 cells-bearing nude mice[J]. Journal of China Pharmaceutical University, 2015, 46(3): 355-358. DOI: 10.11665/j.issn.1000-5048.20150316
    [8]ZHANG Qian, CHEN Cen, YANG Fengqing, XIA Zhining. Mechanism of agonist-induced platelet activation and research progress of anti-platelet drugs[J]. Journal of China Pharmaceutical University, 2014, 45(6): 632-648. DOI: 10.11665/j.issn.1000-5048.20140604
    [9]SONG Huayuan, ZHOU Danli, HAN Yuan, LIU Wentao. Baicalin attenuates morphine tolerance through suppressing spinal microglia activation in mice[J]. Journal of China Pharmaceutical University, 2014, 45(3): 346-351. DOI: 10.11665/j.issn.1000-5048.20140317
    [10]CHENG Yu-si, DAI De-zai, JI Hui, DAI Yin. Mechanism of endothelin receptor antagonist CPU0213 and calcium antagonist CPU86017 ameliorated rats′ heart failure induced by isoproterenol[J]. Journal of China Pharmaceutical University, 2011, 42(1): 58-63.

  • Cited by

    Periodical cited type(4)

    1. 谢金平，黄淼，朱梦雅，陈怡，邵蓉. 监管科学视角下增材制造(3D打印)药物研发上市关键问题及监管政策研究. 中国食品药品监管. 2025(02): 50-61 .
    2. 王美晴，段小群. 3D打印技术在药物制剂领域的研究进展. 广东化工. 2024(02): 67-68+62 .
    3. 张隽齐，杨柳榴，陈芳. 3D打印技术在膜剂制备中的研究进展. 中国医药工业杂志. 2024(03): 326-334 .
    4. 谭志柱，梁兆铭，邓永健. 3D打印技术在汽车轮胎模具领域的应用案例分析. 机电工程技术. 2024(12): 131-134 .

    Other cited types(4)

Catalog

    Get Citation
    PDF
    XML
    Article views (130) PDF downloads (309) Cited by(8)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：365886

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return